NRXS neuraxis.com Company Profit

NRXS (neuraxis.com) - company brandmark

NeurAxis, Inc. (NRXS) neurostimulation technologies are protected by patents and FDA certifications, creating significant barriers to entry. The company's net earned income on this chart visualizes the financial dynamics, where the -0.01 metric determines this level. The combination of high pediatrician brand trust and deep management expertise minimizes risks during the market launch phase of innovative neuromodulation systems.

Net Income: NeurAxis, Inc (NRXS) for 02/21/2024 - 10/30/2026

Financial and market metric breakdowns for NeurAxis (NRXS)

- stock value and consensus price forecast:
Market Price NeurAxis Inc|NRXS - Price Target Chart
- market capitalization data:
Market Capitalization NeurAxis Inc|NRXS - Enterprise Value
- book capitalization information:
Net Asset Value per Share NeurAxis|NRXS - Company Net Assets|Market Capitalization to Book Value Ratio neuraxis.com|NRXS - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio NeurAxis, Inc.|NRXS - Long-Term Debt to Capital|Short-Term Debt to Capital NeurAxis Inc.|NRXS - Company Total Debt|Debt to Book Value Ratio NeurAxis Inc|NRXS - Company Long-Term Debts|Short-Term Debt Volume NeurAxis|Interim Coverage Ratio neuraxis.com
- company profitability and valuation multiples indicators:
NRXS - Net Income
Summary company analysis:NeurAxis Inc
Manufactured products of NeurAxis

Supply chain stability for components and the humanitarian status of neurostimulation minimize external risks for NeurAxis, Inc. By analyzing the company's current net income, an investor sees the final result of converting operating revenue into real capital after all expenses, which allows for an objective assessment of the asset's fundamental value and the risk of overpaying for the stock.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|Company Profit RGC (regencellbioscience.com)|Net Profit AXSM|ACAD - Company Net Income|Xenon Pharmaceuticals Inc - Net Income|Net Profit Viking Therapeutics Corp VKTX|SUPN - Company Net Income|Final Profit CPRX (catalystpharma.com)|DNLI: Net Profit|Harmony Biosciences Inc (HRMY) - Net Profit|Net Income BHVN|Company Profit AMLX (Amylyx Corp)|Net Profit TRVI|Net Financial Result praxismedicines.com|Company Net Income Anavex Life Sciences Corp. AVXL|Net Financial Result CeriBell Inc (CBLL)|PRTA: Net Income|Final Profit ALEC (Alector, Inc.)|ANNX: Net Profit|OMER - Net Financial Result|Company Net Income Neurogene|Company Profit ACIU (AC Immune S.A.)|Net Profit VYGR|Net Income Neumora Corp NMRA|Scilex Holding Company - Net Income|Net Financial Result tevogen.com (TVGN)|ACOG - Company Net Income|CGTX (cogrx.com) - Company Profit|Inhibikase (IKT) - Company Net Income|Cassava Pharma - Final Profit|Net Income ASRT|Company Profit COYA (Coya)|Company Net Income Vistagen Therapeutics (VTGN)|Net Financial Result ovidrx.com|Company Net Income Acumen Pharma ABOS|CRVO: Company Profit|Alterity Therapeutics Ltd - Net Profit|Company Net Income Clene Inc.|PEPG (pepgen.com) - Net Income|jupiterneurosciences.com (JUNS) - Net Profit|Company Net Income Relmada|ANVS: Final Profit|Company Net Income Grace Therapeutics, Inc. (GRCE)|AIFF - Company Net Income|Company Net Income Klotho Neurosciences KLTO|NRSN: Company Profit|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|HSDT (heliusmedical.com) - Net Income|Passage Bio (PASG) - Net Profit|Company Net Income Neuphoria Therapeutics, Inc.|NERV: Final Profit|Net Profit ATHA|Net Profit Addex (ADXN)|Alzamend Neuro - Net Income|CYCN: Company Profit|Protagenic - Net Profit|Net Financial Result Pasithea Therapeutics KTTA|cortigent.com (CRGT) - Company Net Income|ATXI - Net Financial Result|Net Income BCLI|CARA: Final Profit|Net Profit CHRO|Net Financial Result eliemtx.com|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH: Company Profit|Marinus Pharmaceuticals - Net Profit|nkgenbiotech.com (NKGN) - Net Income|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|SAGE - Net Financial Result|Company Net Income Neurotrope|Company Profit TRVN (Trevena Inc)|Company Net Income Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Final Profit|Cerevel Therapeutics, Inc. - Net Income